Yuanbao Inc. – Sponsored ADR (NASDAQ:YB – Get Free Report) was down 8.8% during mid-day trading on Monday . The company traded as low as $12.72 and last traded at $12.69. 51,357 shares traded hands during trading, an increase of 22% from the average session volume of 42,212 shares. The stock had previously closed at $13.91.
Analysts Set New Price Targets
Separately, Weiss Ratings upgraded shares of Yuanbao from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, August 5th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Yuanbao currently has a consensus rating of “Hold” and a consensus target price of $21.80.
View Our Latest Analysis on Yuanbao
Yuanbao Trading Down 7.7%
Yuanbao (NASDAQ:YB – Get Free Report) last released its quarterly earnings data on Friday, September 11th. The company reported $1.26 EPS for the quarter. The business had revenue of $204.92 million for the quarter. Yuanbao had a net margin of 29.91% and a return on equity of 43.75%.
Institutional Trading of Yuanbao
A number of institutional investors have recently modified their holdings of YB. Susquehanna International Group LLP bought a new position in Yuanbao in the 3rd quarter worth approximately $59,613,000. Barclays PLC lifted its position in shares of Yuanbao by 68.7% during the fourth quarter. Barclays PLC now owns 41,988 shares of the company’s stock worth $851,000 after acquiring an additional 17,105 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Yuanbao by 53.7% during the third quarter. JPMorgan Chase & Co. now owns 33,226 shares of the company’s stock worth $653,000 after acquiring an additional 11,607 shares in the last quarter. Federated Hermes Inc. bought a new position in shares of Yuanbao in the second quarter worth $370,000. Finally, Ramsey Quantitative Systems purchased a new position in shares of Yuanbao in the second quarter valued at $160,000.
About Yuanbao
Yuanbao Inc (NASDAQ: YB) is a China-based insurance technology company that operates a digital platform for the distribution of insurance products. The company uses online and mobile channels to connect consumers with insurance offerings from participating insurers.
Yuanbao’s business primarily focuses on health and life insurance products, along with related digital insurance services. Its platform is designed to support product discovery, application, and policy management, while helping insurance providers reach individual customers through technology-enabled distribution.
The company serves customers in China through its online platform.
Featured Articles
- Five stocks we like better than Yuanbao
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
- Rocket Lab Insiders Are Selling—But Institutions Keep Buying
- 3 European Defense Stocks Raising Guidance While the Sector Lags
Receive News & Ratings for Yuanbao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yuanbao and related companies with MarketBeat.com's FREE daily email newsletter.
